Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BACT Genomics 〉Targeted Genomic Profiling Service

Targeted Genomic Profiling Service

Targeted Genomic Profiling Service

Most powerful in targeted therapy, and hormonal therapy evaluation.
NGS panel design of 40 genes and provide medical report in 14 calendar days.

Request for Collaboration
Overview
ACTDrug®+ : Targeted Genomic Profiling Service is used to examine the genetic mutations in cancer patients for their personalized treatment plan. It is a breakthrough product to support current clinical guideline. Using next generation sequencing (NGS) to test 40 druggable genes.
 
Features
  • Most powerful in targeted therapy selection
  • NGS panel design of 40 genes includes genes related to pharmacogenomics beside targeted  therapy  and hormonal therapy.
  • AI-powered bioinformatics analysis of cancer genetic mutations of SNV & Indel and CNV in cancer signaling pathways.
  • High-quality test result in CAP-certified lab
  • Fast turnaround time with 14 calendar days  
Specifications
  • Next Generation Sequencing : 40 druggable genes
  • Hotspots: > 3800
  • NGS Sequencing Mean Depth:>800 X
  • Sample Types : FFPE (5-20 unstained sections : 10µm/slide and 1H&E stained slide : 5µm)                                                               *Cell block from pleural effusion, ascites or pericardial hydrops (≥1X106cells)
  • Additional Test for ACTFusion™: Comprehensive testing of 31 fusion genes and 182 fusion transcripts
Application
All solid tumor patients including common cancer types such as breast, lung, colorectal cancer.
Especially powerful to find effective drug options in the following situations:
  •  Newly diagnosed
  •  Not Heavily treated
  •  Patients planning to use targeted therapy
Collaboration Options
  • Clinical Services : Provide cancer genomic profiling to enable personalized treatment plan.
  • Biomarker Discovery : We provide comprehensive cancer genomic profiling to facilitate biomarker discovery. Customized assay is available.
  • Patient Stratification : From next generation sequencing, IHC and PCR assay, we utilize various platforms to screen patients prospectively.
  • Consultation : Our team of industry veterans and in-house clinical database offer insights to ensure smooth clinical trial operations.
  • CDx Development : We offer companion diagnostic development on NGS-based or CHIP-based multiplex qPCR platforms.
People who like this also like
  • U-Motion II⁺™U-Motion II⁺™
  • U2™ Revision StemU2™ Revision Stem
  • GB KIWI e2000GB KIWI e2000
  • Facial Dermal ImplantFacial Dermal Implant
  • U-Motion II™U-Motion II™
  • Preventive Genetic TestingPreventive Genetic Testing
  • U2™ Cemented StemU2™ Cemented Stem
  • Smart Care SystemSmart Care System
  • GB HBV RealQuant™ PCR KitGB HBV RealQuant™ PCR Kit
  • SB03SB03